Lv11
54 积分 2023-12-20 加入
Discovery of HZS60 as a Novel Brain Penetrant NMDAR/TRPM4 Interaction Interface Inhibitor with Improved Activity and Pharmacokinetic Properties for the Treatment of Cerebral Ischemia
3小时前
待确认
Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury
2个月前
已完结
Discovery of novel tryptamine derivatives as GluN2B subunit-containing NMDA receptor antagonists via pharmacophore-merging strategy with orally available therapeutic effect of cerebral ischemia
2个月前
已完结
GluN2B/N-methyl-D-aspartate receptor antagonists: Advances in design, synthesis, and pharmacological evaluation studies
2个月前
已关闭
Design, Synthesis, and Biological Evaluation of Pierardine Derivatives as Novel Brain-Penetrant and In Vivo Potent NMDAR-GluN2B Antagonists for Ischemic Stroke Treatment
2个月前
已完结
Excitotoxicity and oxidative stress in glutamate-induced SH-SY5Y cell death
4个月前
已完结
Global Disparities of Hypertension Prevalence and Control
11个月前
已完结
Current Landscape of Therapeutics for the Management of Hypertension - A Review
11个月前
已完结
Distinct binding mode of BAFF antagonist antibodies belimumab and tabalumab, analyzed by computer simulation
1年前
已完结
皖公网安备34019202002308
